Control costs, increase efficiency and accelerate your clinical programs with our globally integrated bioanalytical solutions
Effective drug development requires accurate testing, specialized support and precise results. From preclinical to early and late clinical phases, we provide comprehensive bioanalytical solutions for your drug development.
With over 30 years of experience, operating out of our GLP/GCP compliant laboratories, we provide expertise to develop assays from scratch. We also support large-scale routine sample analyses – from regulatory pre-clinical (toxicology) to early and late clinical studies (Phase I to IV). We have also recently gained enhanced testing capabilities with advanced ELISA equipment and the Gyrolab xPlore system.
Why choose bioanalytical solutions from SGS?
- Method transfer, development, and validation:
Small molecules, biologics, biosimilars and biomarkers
- PK bioanalysis:
Small molecules, biologics and biosimilars
- PD bioanalysis:
Soluble and cellular biomarkers
- Immunogenicity testing:
Screening, confirmatory, titration characterization and neutralizing antidrug antibody assays
- ELISA and multiplex assays:
Parent drug, metabolites, and biomarkers
- Bioassays:Cellular biomarkers, receptor occupancy, neutralizing anti-drug antibody assays and immunophenotyping
- Hybrid approach:
LBA/LC-MS/MS:
- Enzyme digestion of biopharmaceutical drug and quantification of signature peptide(s) by LC-MSMS
- Enzymatic digest with immune capture of a signature drug peptide fragment followed by LCMSMS quantification
Why choose SGS?
We are the world’s leading inspection, verification, testing and certification company. In addition to our bioanalytical solutions, we offer industry-leading contract development and manufacturing (CDMO), and analytical development and testing.
We support you every step of the way to enable you to deliver first-class, fully compliant biopharmaceutical and pharmaceutical drugs, clinical research, and medical devices.
To discuss your bioanalytical requirements, contact us today.